Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression
about
Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicityTobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophagesConstruction of predictive promoter models on the example of antibacterial response of human epithelial cellsKruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cellsMarkers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsCritical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical TrialsSequential activation of Elk-1/Egr-1/GADD45α by arsenicThe principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory statesPhosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophagesCarbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genesABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responsesSerotonin Receptor 4/6/7 and NR3C SignalingSerotonin Receptor 2 and ELK-SRF/GATA4 signalingVenous thromboembolism in malignant gliomasInhibitory effect of 1,8-cineol (eucalyptol) on Egr-1 expression in lipopolysaccharide-stimulated THP-1 cells.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes.The expression of vasoactive intestinal peptide receptor 1 is negatively modulated by microRNA 525-5p.Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages.Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.PML/RARalpha fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA associationAtorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling.Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility.Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new playerCarbon monoxide induced PPARγ SUMOylation and UCP2 block inflammatory gene expression in macrophagesTLR signaling paralyzes monocyte chemotaxis through synergized effects of p38 MAPK and global Rap-1 activationSex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expressionSuppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury.Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-RasDiverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cellsSex differences in monocyte activation in systemic lupus erythematosus (SLE).Egr-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1/2 and JNK signaling pathwaysMonocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity.Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response.Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.Moderate alcohol induces stress proteins HSF1 and hsp70 and inhibits proinflammatory cytokines resulting in endotoxin tolerance.Regulation of cyclooxygenase-2 in renal medulla.
P2860
Q21284512-28A8BAC0-32FF-4EC5-A309-C96EEA5A77DCQ24608957-45F118B7-657C-4743-8ACC-491D77B2FA1CQ24796048-7391AB55-5D19-43DF-AFA8-91AFE424FFE0Q25255397-61E43F40-57BE-4CCD-BDA9-86F29E0985BEQ27024262-4B9CE398-F845-4F32-92FC-2CDDCF9ACB55Q28073542-83BB374B-6586-47CC-90CC-F552A3859803Q28391425-D74A052C-72C4-4186-93BB-A20A1D8F400AQ28396048-4F229498-FA0C-42C9-85B2-B83F9C801D8BQ28505138-6F916ACC-8F99-42C0-905C-79689E3B86B9Q28578483-07B5440A-1A54-4EF3-91DF-02236E8F513EQ28585458-2D912F77-62BB-4799-9C5B-2D965076B8BEQ30230753-C3A3A260-1AAF-42A3-9025-BC0C9BEDEAA2Q30230906-31FE9568-FD0A-49D3-B86F-F4A4D931CD93Q30436810-53E2028A-31EA-44A9-AFBF-82108F1BCCDFQ33284849-91A69115-A81A-4376-A6B8-49369858A4D1Q33364401-B8EBA5ED-F59C-43AC-B3CE-2219CCAAC09CQ33510461-F86634DA-1914-4561-8C11-B95647E9E7B4Q33656489-1C4D01C9-01EA-4063-B658-AC793CAD1DC8Q33710188-D4210A22-F291-47BB-80F2-A74D998075D1Q33730481-F50FC1E5-2786-4C06-B332-5DB40268DB5DQ33734488-FBCBA23F-D0B5-4128-AC77-11751DF310BEQ33769398-992EEF5C-DA6E-485D-A8AF-78C3E202E6D3Q33829542-F8984289-FB78-4B10-8B12-6C32C4145387Q33877053-51B55ACD-0211-4487-900E-A32015071898Q33976689-72E264F8-8444-41DC-92FC-49C28EAF3CCBQ34064427-E4A799B9-E543-413C-AF0F-5C298B3F6F77Q34162512-D48AB0BB-7D24-4619-B48A-8A6C8A92BDF5Q34323715-925C359F-380D-4C71-90DA-1A3CCE1ECEB2Q34347611-30921344-E645-4E6B-B40D-5DB9F34B5C60Q34453628-1D319BC6-000C-4C05-8E35-00009D7FEAE6Q34468320-AF8221B6-DF86-4FF9-AE68-D9DF0FC6D83DQ34480231-662D88D3-C5FD-46FF-BBB0-763D71B44F4CQ34653871-32F83A69-6AB7-4CC5-AE43-199826F55245Q34690943-AC669507-33C6-4292-B0E2-6E32E732D919Q34701209-C64FD73E-FCC3-4454-AB27-0A8FB46CF475Q34992935-CAB1B1FD-CBA2-4BBD-8B02-FB98D0D59169Q35037308-8DFEC1D2-DB19-4357-B667-C7A016B926DBQ35047129-AFE74433-1765-40D5-BAD6-BB0B0F9FD469Q35077485-1A6628CE-2A6B-48E6-A00F-8C987D0908BEQ35089190-3171DCE8-EB61-4C62-A6F7-F4E0B2FA4E48
P2860
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression
description
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/09/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/09/01)
@nl
наукова стаття, опублікована у вересні 2001
@uk
مقالة علمية (نشرت في سبتمبر 2001)
@ar
name
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@ast
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@en
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@nl
type
label
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@ast
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@en
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@nl
prefLabel
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@ast
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@en
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@nl
P2093
P3181
P356
P1433
P1476
Lipopolysaccharide activation ...... orylation and Egr-1 expression
@en
P2093
M. A. O'Connell
N. Mackman
P. McGovern
R. Pawlinski
P304
P3181
P356
10.1182/BLOOD.V98.5.1429
P407
P577
2001-09-01T00:00:00Z